Psychological Disorders - Complete Interactive Lesson
Part 1: Classifying Disorders: DSM Logic, Anxiety, OCD & Trauma
Psychological Disorders
Part 1 of 4 — Classifying Disorders: DSM Logic, Anxiety, OCD & Trauma
What Makes Something a Disorder?
No single feature suffices. The working standard combines:
- Dysfunction in psychological, biological, or developmental processes
- Distress to the person and/or impairment in social, occupational, or daily functioning
- NOT merely: statistical rarity, social deviance, or conflict with society — unusual beliefs, nonconformity, or protest alone never qualify
The DSM-5 is the classification standard: categorical (diagnosis met or not, via symptom-count and duration criteria), deliberately atheoretical about causes. The dominant explanatory frame is biopsychosocial — and the diathesis-stress model (a predisposition expressed only under sufficient stress) is its workhorse. Contrast with a purely biomedical model, which the MCAT usually presents as too narrow.
Anxiety Disorders (fear/worry disproportionate and impairing)
| Disorder | Core pattern | Discriminating detail |
|---|---|---|
| Generalized anxiety disorder | Excessive, uncontrollable worry about MANY domains, more days than not, ≥ 6 months, with somatic tension/sleep/concentration symptoms | Breadth + duration + uncontrollability separate it from normal worry |
| Specific phobia | Intense fear of a particular object/situation; immediate response; avoidance | Person usually recognizes the fear as excessive |
| Social anxiety disorder | Fear of scrutiny and negative evaluation in social/performance situations | Fear of embarrassment specifically |
| Panic disorder | Recurrent unexpected panic attacks (surge peaking in minutes: palpitations, dyspnea, derealization, fear of dying) PLUS ≥ 1 month of worry about attacks or maladaptive behavior change | The attack is an event; the DISORDER is the fear-of-the-fear cycle. Attacks mimic cardiac emergencies — passages love the ER vignette with a normal workup |
| Agoraphobia | Fear/avoidance of situations where escape/help might be unavailable (crowds, transit, open/enclosed spaces) | Often, but not necessarily, follows panic attacks |
Obsessive-Compulsive & Related
- Obsessions: intrusive, unwanted, anxiety-producing thoughts/urges/images the person tries to suppress — recognized as products of their own mind
- Compulsions: repetitive behaviors or mental acts performed to neutralize obsession-driven anxiety or by rigid rules
- The maintaining engine is negative reinforcement (learning lesson tie-in): the ritual briefly removes anxiety, strengthening the ritual — which is why exposure WITH response prevention is the behavioral treatment
- Related disorders run the same loop with different content: body dysmorphic disorder (preoccupation with a perceived flaw, mirror-checking) and hoarding disorder (distress at discarding)
Trauma & Stressor-Related
PTSD requires a qualifying traumatic exposure plus four symptom clusters:
- Intrusion (flashbacks, nightmares, intrusive memories)
- Avoidance of reminders
- Negative alterations in cognition/mood (blame, detachment, anhedonia)
- Alterations in arousal/reactivity (hypervigilance, exaggerated startle, sleep disturbance)
Duration boundary: symptoms > 1 month = PTSD; a similar picture lasting up to 1 month = acute stress disorder. Adjustment disorder = disproportionate distress after a stressor, usually an ordinary one; after a trauma it applies only when PTSD or acute stress disorder criteria are not met.
<!-- yield:low -->- Acute stress disorder's window formally runs from 3 days to 1 month after the trauma.
Worked Example — An Emergency-Department Vignette, Fully Read
Problem 1. A 23-year-old student has had three episodes in six weeks of abrupt palpitations, breathlessness and a sense of dying, peaking within ten minutes and gone within the hour. Cardiac and thyroid workups are normal. The episodes "come out of nowhere," one waking her from sleep.
- (a) What are the episodes themselves?
- (b) Why does the normal medical workup matter?
- (c) What does "out of nowhere," including from sleep, tell you?
- (d) She also has long-standing, manageable nervousness before presentations. Does it justify a social anxiety diagnosis?
(a) Panic attacks. An abrupt surge that peaks within minutes and resolves within the hour, a somatic storm, and catastrophic cognition make each episode a panic attack. An attack is an event, not yet a diagnosis.
(b) Mimics removed. Cardiac and thyroid disease are the great mimics of panic, and any competent item mentions ruling them out. A normal workup is the vignette's signal to think panic.
(c) Unexpected attacks. Attacks without a trigger, even from sleep, are UNEXPECTED. That points away from specific phobia and social anxiety, where attacks are cued by an identifiable trigger.
(d) No. Her presentation nervousness is subclinical and situational. It is a distractor planted to invite an unjustified social anxiety diagnosis.
Problem 2. The same student, since her first episode six weeks ago, has stopped attending lectures held in the large auditorium, sits near exits, and repeatedly checks her pulse.
- (a) Does she now meet criteria for panic disorder?
- (b) What does avoiding the auditorium and sitting near exits signal?
- (c) What cycle keeps the attacks coming?
- (d) Which behavioral treatment follows, and what must happen to the pulse-checking and exit-sitting?
(a) Yes, from the inter-attack syndrome. The diagnosis rests on what happens BETWEEN attacks: recurrent unexpected attacks followed by a month-plus of worry about more attacks or maladaptive behavior change. Her six weeks of avoidance and pulse-checking supply it; attacks alone would not suffice.
(b) Early agoraphobia. Avoiding places where escape would be hard if an attack struck is early agoraphobic avoidance. If it generalizes to two or more situation types (transit, crowds, leaving home) for 6+ months, agoraphobia becomes a second diagnosis.
(c) An interoceptive loop. Bodily sensations → catastrophic appraisal → sympathetic surge → stronger sensations. Each pass through the loop confirms the fear.
(d) Interoceptive exposure. Deliberately inducing the feared sensations breaks the association. The safety behaviors must be withdrawn, because they act as negative reinforcers that preserve the fear: the same operant engine as OCD rituals.
DSM Logic, Anxiety & Trauma 🎯
Key Takeaways — Part 1
- DSM logic. DSM-5 is categorical and atheoretical; diathesis-stress (vulnerability plus stress) is the default causal frame.
- The anxiety map. GAD: broad, uncontrollable worry for 6+ months; phobias: cued fear; agoraphobia: fear of no escape.
- OCD runs on relief. Rituals remove obsession-driven anxiety (negative reinforcement); exposure with response prevention treats it.
- PTSD by the calendar. Four clusters: over 1 month is PTSD, up to 1 month acute stress disorder; adjustment: ordinary stressor.
Common traps
- Diagnosing the attack. A panic attack is an event; panic disorder needs a month of worry or behavior change between attacks.
- Rarity as disorder. Rare or socially deviant views are not a disorder without dysfunction and distress or impairment.
- Cued vs. uncued. Attacks with a clear trigger point to phobia or social anxiety; attacks "out of nowhere" point to panic.
- Rituals as reward. Compulsions persist because they remove anxiety (negative reinforcement), not because they please.
Low-yield extras
- Acute stress disorder's formal window starts 3 days after the trauma.
Part 2: Mood Disorders & Schizophrenia
Psychological Disorders
Part 2 of 4 — Mood Disorders & Schizophrenia
Major Depressive Disorder (MDD)
Diagnosis requires ≥ 5 symptoms for ≥ 2 weeks, including at least one of the two cardinal symptoms:
- Depressed mood most of the day, nearly every day
- Anhedonia — markedly diminished interest or pleasure
Plus: appetite/weight change, insomnia or hypersomnia, psychomotor agitation/retardation, fatigue, worthlessness or inappropriate guilt, impaired concentration, recurrent thoughts of death. Persistent depressive disorder (dysthymia): milder but chronic — depressed mood more days than not for ≥ 2 years. Seasonal pattern responds to light therapy.
- Monoamine hypothesis (a biological correlate, not a proven single cause): reduced serotonin/norepinephrine signaling; supported by antidepressant pharmacology, but the weeks-long therapeutic lag despite immediate synaptic effects shows it is incomplete (current work emphasizes downstream neuroplasticity)
- The best-studied neuroplasticity signal is brain-derived neurotrophic factor (BDNF), which chronic antidepressant treatment raises.
- HPA axis hyperactivity (elevated cortisol) and reduced hippocampal volume in chronic illness — again correlates, not causes
Suicide risk assessment is part of any depression vignette: prior attempts, plan and means, hopelessness, substance use, social isolation — asking about suicide does NOT increase risk.
Bipolar Disorders (defined by the ELEVATED pole)
| Diagnosis | Requirement | Depression required? |
|---|---|---|
| Bipolar I | ≥ 1 manic episode: ≥ 1 week (or any duration if hospitalized) of elevated/irritable mood + increased energy, with grandiosity, decreased need for sleep, pressured speech, flight of ideas, distractibility, risky spending/behavior; severe impairment, possibly psychotic features | No — mania alone suffices |
| Bipolar II | ≥ 1 hypomanic episode (≥ 4 days, same symptom list but NO marked impairment, NO psychosis, NO hospitalization) + ≥ 1 major depressive episode | Yes |
| Cyclothymia | ≥ 2 years of subthreshold hypomanic and depressive fluctuations | Subthreshold both poles |
Discriminator: decreased need for sleep (rested after 3 hours) vs. insomnia (tired, cannot sleep). First-line mood stabilizer: lithium; antidepressant monotherapy risks switching a bipolar patient into mania.
Schizophrenia (psychosis = break with reality testing)
Two or more of five criteria (delusions, hallucinations, disorganized speech, disorganized/catatonic behavior, negative symptoms) for a 1-month active phase, with continuous disturbance ≥ 6 months and major functional decline; at least one must be delusions, hallucinations, or disorganized speech. The criteria group as:
- Positive symptoms (added to experience): delusions (fixed false beliefs — persecutory, grandiose, referential), hallucinations (perceptions without stimuli — auditory most common), disorganized speech (derailment, word salad)
- Grossly disorganized or catatonic behavior
- Negative symptoms (subtracted): flat/blunted affect, avolition (loss of motivation), alogia (poverty of speech), anhedonia, asociality — these predict functional outcome best and respond worst to classic drugs
Beyond the diagnostic criteria, cognitive symptoms (working memory, attention deficits) are increasingly emphasized.
Timeline: prodrome (withdrawal, odd beliefs) → active phase → residual. Schizophreniform = same picture 1-6 months; brief psychotic disorder < 1 month; schizoaffective = psychosis meeting schizophrenia criteria PLUS major mood episodes, with delusions/hallucinations also present at times WITHOUT mood symptoms.
<!-- yield:low -->- Schizoaffective disorder's formal rule: at least 2 weeks of delusions or hallucinations in the absence of a major mood episode.
Dopamine hypothesis: excess mesolimbic dopamine → positive symptoms (supported by D2-blocking antipsychotics and amphetamine-induced psychosis); mesocortical HYPOactivity linked to negative/cognitive symptoms — one transmitter, two pathways, opposite directions. Glutamate (NMDA hypofunction) is the major newer thread. Etiology: strong heritability + prenatal insults + stress — the diathesis-stress showcase.
Worked Example — A Two-Pathway Pharmacology Passage, Fully Read
Problem 1. A 21-year-old junior has had a month of conviction that campus cameras broadcast his thoughts, two voices commenting on his actions, and tangential speech. His roommate describes a year of withdrawal, declining hygiene and abandoned activities before that.
- (a) Which of his symptoms are positive symptoms?
- (b) What is the year that came before, and which symptoms does it contain?
- (c) Does his course meet schizophrenia's duration criteria?
(a) The active phase. The thought-broadcasting delusion, the commenting voices and the tangential speech are all positive symptoms, and together they make up a 1-month active phase.
(b) The prodrome. The preceding year of withdrawal and decline is the prodrome. Its abandoned activities and withdrawal (avolition, asociality) are negative symptoms.
(c) Yes. A 1-month active phase plus a year of prodrome exceeds the 6 months of continuous disturbance. Both criteria columns are satisfied: the vignette is built to make you assemble the timeline.
Problem 2. On a D2-antagonist antipsychotic, his voices and delusion fade within weeks, but he remains flat, unmotivated, and socially disengaged; he also develops tremor and rigidity.
- (a) What does the relief of his voices and delusion suggest about mesolimbic dopamine?
- (b) Why do the flat affect and low motivation persist?
- (c) Where do the tremor and rigidity come from?
(a) Mesolimbic excess. D2 blockade relieves positive symptoms, which is consistent with mesolimbic dopamine EXCESS.
(b) Mesocortical hypofunction. Negative symptoms fit an underactive mesocortical pathway. Blocking dopamine cannot fix a pathway that is already underactive, and it may worsen it.
(c) The nigrostriatal pathway. D2 blockade in this third pathway produces parkinsonism. Connect it to Parkinson's disease pharmacology, where the therapeutic direction is reversed.
Problem 3. A research aside notes that amphetamine at high doses reproduces paranoid psychosis in healthy users, and that an NMDA antagonist (ketamine) transiently produces BOTH positive-like and negative-like symptoms in volunteers.
- (a) What does the amphetamine finding support?
- (b) What does the ketamine finding add?
(a) Dopamine for positive symptoms. Amphetamine, a dopamine releaser, reproduces ONLY paranoid positive symptoms. That supports dopamine's sufficiency for that cluster.
(b) Glutamate upstream. Ketamine reproducing both clusters is the standard argument that NMDA/glutamate hypofunction sits upstream. It explains what the dopamine hypothesis alone cannot: the negative and cognitive symptoms.
Problem 4. A passage item asks which feature best distinguishes his negative symptoms from a co-occurring major depressive episode.
- (a) What would mark a major depressive episode?
- (b) What marks primary negative symptoms?
- (c) What course would bring schizoaffective disorder into the differential?
(a) Depressed mood. Depression carries prominent depressed MOOD and guilt, with idea generation intact.
(b) Absence. Primary negative symptoms present as absence: flat affect and avolition without the subjective sadness. They also predate the mood-reactive picture.
(c) Mood episodes plus psychosis outside them. If a full mood episode dominated the course while psychosis also persisted outside it, schizoaffective disorder would enter the differential. Course bookkeeping decides.
Mood Disorders & Psychosis 🎯
Key Takeaways — Part 2
- MDD criteria. Five symptoms for 2+ weeks, one being depressed mood or anhedonia; dysthymia is milder but lasts 2+ years.
- Bipolar bookkeeping. Mania (1+ week, or hospitalized) = Bipolar I; hypomania (4+ days) + major depression = II; cyclothymia: 2 years subthreshold.
- Schizophrenia criteria. Two of five symptoms, one of them core psychotic: a 1-month active phase within 6+ months.
- Dopamine, two pathways. Mesolimbic excess is linked to positive symptoms; mesocortical deficit to negative ones.
Common traps
- Need vs. inability to sleep. Feeling rested on 3 hours is decreased need for sleep (mania); insomnia is tired yet sleepless.
- Requiring depressed mood. Anhedonia can replace depressed mood as the cardinal symptom of MDD.
- Calling short psychosis schizophrenia. Under 1 month is brief psychotic disorder; 1–6 months is schizophreniform.
- Fearing to ask about suicide. Asking directly assesses risk and does not create it.
Low-yield extras
- BDNF as the best-studied neuroplasticity signal in depression; schizoaffective disorder's formal 2-week rule for psychosis without a mood episode.
Part 3: Personality, Dissociative, Somatic & Neurocognitive Disorders
Psychological Disorders
Part 3 of 4 — Personality, Dissociative, Somatic & Neurocognitive Disorders
Personality Disorders (enduring, inflexible, pervasive patterns from early adulthood)
Personality disorders are enduring, inflexible patterns, present from early adulthood and stable across situations. They are ego-syntonic (experienced as "just how I am") — a key contrast with the ego-dystonic distress of anxiety disorders — and are grouped in three clusters:
-
Cluster A — odd/eccentric (social detachment, suspicion): paranoid (pervasive distrust); schizoid (genuine indifference to relationships, flat); schizotypal (eccentric beliefs, magical thinking, perceptual oddities — schizophrenia-spectrum but no frank psychosis)
-
Cluster B — dramatic/erratic (emotion dysregulation, self-focus): antisocial (violation of others' rights, deceit, lack of remorse; ≥ 18 with conduct disorder history before 15); borderline (unstable relationships/self-image/affect, abandonment terror, splitting — all-good/all-bad, self-harm risk); histrionic (attention-seeking emotionality); narcissistic (grandiosity, need for admiration, fragile self-esteem beneath)
-
Cluster C — anxious/fearful (anxiety-driven rigidity): avoidant (desires closeness but fears rejection — contrast schizoid's indifference); dependent (submissive clinging, cannot decide alone); obsessive-compulsive personality disorder (OCPD) (perfectionism and control as a worldview)
OCD vs. OCPD — a guaranteed item: OCD has intrusive obsessions and anxiety-driven rituals the person finds alien (ego-dystonic); OCPD is a lifelong, ego-syntonic perfectionism with NO true obsessions or compulsions — the person endorses the standards, others suffer them.
Dissociative Disorders (disrupted integration of memory, identity, perception)
- Dissociative identity disorder: ≥ 2 distinct personality states with recurrent gaps in recall; strongly associated with severe early trauma; controversial but tested descriptively
- Dissociative amnesia: inability to recall important autobiographical information, usually trauma-linked, beyond ordinary forgetting — may include fugue (sudden travel with identity confusion)
- Depersonalization/derealization disorder: recurrent detachment from self (observing oneself from outside) or surroundings (world feels unreal), with intact reality testing — the person knows the experience is "not real," which separates it from psychosis
Somatic Symptom & Related Disorders (distress expressed through the body)
- Somatic symptom disorder: ≥ 1 distressing physical symptom PLUS excessive thoughts/anxiety/time devoted to it — the symptom may or may not have medical explanation; the DISORDER lies in the disproportionate response
- Illness anxiety disorder: preoccupation with HAVING a serious disease with minimal or no somatic symptoms
- Conversion disorder (functional neurological symptom disorder): neurological deficits (paralysis, blindness, seizures) incompatible with recognized pathology — deficits are NOT consciously produced
- Contrast: factitious disorder (classified in this same DSM-5 chapter, but symptoms are intentionally produced) = intentional symptom production for the sick ROLE; malingering = intentional production for EXTERNAL gain (not a mental disorder)
Neurocognitive Disorders (the biological-psychology bridge)
| Alzheimer's disease | Parkinson's disease | |
|---|---|---|
| Pathology | Amyloid-beta plaques, neurofibrillary tau tangles, cortical/hippocampal atrophy, acetylcholine deficit | Substantia nigra degeneration → striatal dopamine deficit; Lewy bodies (alpha-synuclein) |
| Presentation | Insidious memory loss (anterograde first) → language, visuospatial, executive decline | Motor triad: resting tremor, rigidity, bradykinesia; postural instability; dementia may develop late |
| Treatment logic | Cholinesterase inhibitors (symptomatic) | L-DOPA (dopamine precursor crossing the blood-brain barrier) |
Delirium vs. dementia: delirium is ACUTE, fluctuating, with impaired attention/arousal and usually a medical precipitant (infection, drugs) — reversible; dementia is chronic, progressive, with attention relatively spared early.
<!-- yield:low -->- Depression in the elderly ("pseudodementia") can mimic dementia but shows quick, low-effort "I don't know" responses (people with dementia tend to try hard and confabulate) and improves with mood treatment.
Worked Example — A Differential-Sorting Passage, Fully Read
Problem 1. Patient 1, 74, hospitalized with pneumonia: by night two she is agitated, sees IV tubing as snakes, drifts in and out, and cannot hold attention; "sharp as a tack" last week. Patient 2, 71: two years of worsening memory, now lost on familiar routes; alert and attentive.
- (a) What is Patient 1's diagnosis, and how is it treated?
- (b) What is Patient 2's diagnosis, and what is its most likely cause?
- (c) Both have memory trouble. Which axis separates them fastest?
(a) Delirium. Abrupt onset, a FLUCTUATING course, impaired attention and arousal, visual misperceptions and a medical precipitant (infection) make delirium: a reversible emergency, treated by finding the cause.
(b) Alzheimer's dementia. An insidious two-year decline with intact attention is a major neurocognitive disorder. Anterograde-first memory loss with spatial disorientation makes Alzheimer's the leading cause (hippocampus first, plaques and tangles, cholinergic deficit).
(c) Attention. The attention axis, not memory, is the fastest delirium/dementia discriminator: impaired in Patient 1, spared in Patient 2.
Problem 2. Patient 3, 29, has sudden left-arm paralysis after witnessing a violent assault. Reflexes, imaging, and nerve conduction are normal, the "paralyzed" arm steers away from her face when dropped, and she seems strikingly untroubled.
- (a) Which diagnosis fits?
- (b) Why not malingering or factitious disorder?
- (c) Should her calm indifference drive the diagnosis?
(a) Conversion disorder. Normal studies plus a finding no lesion explains (the dropped arm steering clear of her face) make functional neurological symptom disorder (conversion disorder). It often follows a stressor, but DSM-5 does not require one. The deficit is not consciously feigned.
(b) No sign of intent. No external incentive is evident, ruling out malingering, and she is not fabricating symptoms to occupy the sick role, ruling out factitious disorder.
(c) No. The calm indifference is a classically described but nonspecific feature. Do not diagnose on it alone.
Problem 3. Patient 4, 68, has a pill-rolling tremor at rest, cogwheel rigidity, slowed gait with reduced arm swing, and intact cognition.
- (a) Which disease is this, and what is its pathology?
- (b) What treatment follows?
- (c) How do antipsychotics connect to this picture?
(a) Parkinson's disease. Resting tremor + rigidity + bradykinesia is the Parkinson triad: substantia nigra dopaminergic loss with Lewy bodies.
(b) L-DOPA. It replaces the missing dopamine precursor.
(c) A mirror across one transmitter. D2-blocking antipsychotics produce this same picture pharmacologically (Part 2's nigrostriatal pathway), and excess dopamine therapy can produce psychotic symptoms.
Problem 4. The passage adds two staff members, both lifelong loners. One prefers solitude and feels nothing is missing. The other longs for friends but skips every gathering, sure he would be mocked.
- (a) Which personality disorder fits each?
- (b) Which cluster holds each?
- (c) What separates both from the four patients' disorders?
(a) Schizoid, then avoidant. The first is genuinely indifferent to relationships: schizoid. The second wants closeness but fears rejection: avoidant. The behavior is the same; the motive decides.
(b) Cluster A, then Cluster C. Schizoid sits with the odd/eccentric disorders (Cluster A); avoidant sits with the anxious/fearful ones (Cluster C).
(c) Course. Their patterns are lifelong and trait-like, from early adulthood. Each patient's disorder is a change from an earlier baseline, acute (delirium, conversion) or late-life (Alzheimer's, Parkinson's).
Clusters, Dissociation & Neurocognitive Disorders 🎯
Key Takeaways — Part 3
- Personality clusters. A odd (paranoid, schizoid, schizotypal); B dramatic (antisocial, borderline, histrionic, narcissistic); C anxious (avoidant, dependent, OCPD).
- Dissociative disorders. DID (2+ identities, recall gaps), dissociative amnesia (possibly with fugue), depersonalization with reality testing intact.
- The somatic family. Somatic symptom disorder is an excessive response; illness anxiety is disease fear with few symptoms.
- Neurocognitive pairs. Alzheimer's: plaques, tangles, ACh loss; Parkinson's: nigral dopamine loss, Lewy bodies, L-DOPA.
Common traps
- OCD vs. OCPD. OCPD has no true obsessions or rituals; it is ego-syntonic perfectionism, unlike ego-dystonic OCD.
- Schizoid vs. avoidant. Schizoid people are indifferent to relationships; avoidant people want them but fear rejection.
- Delirium as dementia. Acute onset, fluctuation and impaired attention mark delirium; memory trouble occurs in both.
- Conversion as faking. Conversion deficits are not conscious; factitious seeks the sick role, malingering external gain.
Low-yield extras
- Depressive "pseudodementia" in the elderly mimics dementia but gives quick, low-effort "I don't know" answers and lifts with mood treatment.
Part 4: MCAT Integration: Etiology Models, Treatment Logic & Reading Clinical Studies
Psychological Disorders — Deep Dive
Part 4 of 4 — MCAT Integration: Etiology Models, Treatment Logic & Reading Clinical Studies
The Etiology Frameworks (match the mechanism in the stem)
| Framework | Disorder is... | Treatment follows as... |
|---|---|---|
| Biological/biomedical | Neurotransmitter, structural, genetic dysfunction | Medication, brain stimulation |
| Behavioral | Learned associations and reinforcement histories | Unlearning: exposure, conditioning-based methods |
| Cognitive | Distorted appraisals and maladaptive automatic thoughts | Restructuring thoughts (with behavior experiments = CBT) |
| Framework | Disorder is... | Treatment follows as... |
|---|---|---|
| Psychodynamic | Unconscious conflict | Insight-oriented therapy |
| Humanistic | Blocked growth, conditions of worth | Client-centered, unconditional positive regard |
| Sociocultural | Social context, stressors, stigma, inequities | System- and community-level intervention |
Diathesis-stress integrates them; the biopsychosocial answer is usually the credited one when frameworks compete.
Treatment Logic You Can Derive (not memorize)
- Exposure therapies = classical extinction: present the CS (feared object, bodily sensation, memory) without the feared outcome until the fear response extinguishes. Systematic desensitization adds counterconditioning — relaxation paired stepwise up an anxiety hierarchy; flooding starts at the top; exposure + response prevention (OCD) blocks the negatively reinforcing ritual
- Token economies = operant secondary reinforcement in institutional settings; aversion therapy = counterconditioning with an unpleasant US
- Drug-class map (MCAT altitude): SSRIs — first-line for depression AND most anxiety disorders/OCD (weeks-long lag); benzodiazepines — rapid GABA-enhancing anxiolytics, dependence risk, short-term; antipsychotics — D2 blockade (positive symptoms; motor side effects); lithium — bipolar maintenance; cholinesterase inhibitors — Alzheimer's; L-DOPA — Parkinson's
- Psychotherapy + medication generally outperforms either alone for many conditions
Labeling, Stigma & the Rosenhan Problem
- Diagnostic labels enable communication, prediction, and treatment — but carry stigma: labeled individuals face discrimination, and observers reinterpret normal behavior through the label (in Rosenhan's famous pseudopatient study, ordinary note-taking was charted as pathological "writing behavior"). Its methods have been seriously criticized, but the labeling lesson — expectation shapes clinical perception — remains the tested point
- Medicalization: redefining human variation as disorder expands treatment but risks pathologizing normality (connect to the sociology lessons' social-construction thread)
- Respectful framing matters clinically: the person HAS a disorder; the person IS not the disorder
Reading Clinical Studies — the Checklist
- RCT anatomy: random assignment (equates groups on unmeasured confounds), placebo control (expectancy effects are large in psychiatry), double-blinding (patient AND rater expectations)
- Regression to the mean: patients enroll at their worst; untreated improvement is guaranteed on average — the placebo arm absorbs this, which is why "improved from baseline" proves nothing
- Comorbidity (disorders co-occurring at high rates) muddies specificity claims; self-report scales import reporting biases; dropout (attrition) biases completers toward success
- Statistical vs. clinical significance: a tiny symptom-scale difference can be "significant" in a huge sample yet meaningless at the bedside — check effect sizes and functional outcomes
- Diagnostic criteria in passages: count symptoms, check DURATION boundaries (2 weeks MDD; 6 months GAD/schizophrenia; 1 month PTSD/panic's inter-attack worry), and confirm impairment — most pseudo-diagnoses in answer choices fail on duration
Worked Example — An Antidepressant-Trial Passage, Fully Read
Problem 1. 480 adults with moderate MDD are randomized to SSRI, pill placebo, CBT, or waitlist; raters blind to condition score symptoms at 0, 8, and 24 weeks. At 8 weeks: SSRI improves 11.2 points from baseline, placebo 8.1, CBT 10.8, waitlist 4.9 (drug vs placebo p = 0.03, d = 0.28).
- (a) What does the waitlist's improvement estimate?
- (b) What does the placebo arm add on top of that?
- (c) How large is the pharmacological effect?
- (d) Is that effect clinically meaningful?
(a) Natural course. The waitlist's 4.9 points estimate natural course plus regression to the mean: enrollees start near their nadir.
(b) Expectancy and contact. Placebo (8.1) adds expectancy and clinical contact. Never grade any arm against baseline; grade arms against each other.
(c) The drug-minus-placebo gap. Only that gap, 11.2 − 8.1 = 3.1 points (d = 0.28), is the pharmacological effect.
(d) Probably not on its own. p = 0.03 makes it statistically significant, but d = 0.28 is small: a statistical-vs-clinical significance flag.
Problem 2. In the same trial, SSRI and CBT were close at 8 weeks (11.2 vs 10.8 points). At 24 weeks, relapse among responders is 41% after the SSRI is stopped and 22% after CBT. Dropout: 31% SSRI (mostly side effects), 12% CBT.
- (a) What does the relapse comparison show?
- (b) How does the dropout difference bias an analysis of completers only?
- (c) Which analysis is the fix?
(a) CBT lasts. CBT matched the drug acutely (10.8 vs 11.2 points) and roughly HALVES relapse after treatment ends (22% vs 41%): the classic durability advantage of learned skills over discontinued medication.
(b) Toward the drug. Differential dropout (31% vs 12%) leaves the SSRI arm's completers a selected, better-tolerating group, biasing completer analyses toward the drug.
(c) Intention-to-treat. Analyzing everyone as randomized, dropouts included, is the requested fix.
Problem 3. Citing the trial's 8-week drug-placebo gap (11.2 vs 8.1 points), an editorial concludes: "Antidepressants barely beat sugar pills, so depression is not biological."
- (a) Does a modest drug-placebo gap mean the drug does nothing?
- (b) Can a treatment's success or failure tell you a disorder's cause?
- (c) What kind of evidence would an etiology claim need?
(a) No. Placebo arms in depression trials capture real improvement processes (expectancy, contact, regression), inflating the comparator. A modest gap does not mean an inert drug.
(b) Never, in either direction. Aspirin relieving headaches does not prove headaches are aspirin-deficiency diseases, and CBT working does not prove depression is "just thoughts." The editorial commits this category error twice.
(c) Etiological designs. Etiology claims need etiological designs — twin, adoption, and longitudinal studies — not outcome trials.
Problem 4. Expect three follow-up items on the same trial's design.
- (a) Why include a placebo arm rather than a waitlist alone?
- (b) Why blind the raters?
- (c) Which patients does the trial's conclusion cover?
(a) To separate effects. A placebo arm separates expectancy and contact effects from natural course.
(b) Observer expectations. Raters' expectations distort self-report-adjacent measures: the Rosenhan lesson operationalized.
(c) Only those studied. It covers adults with moderate MDD like those enrolled, under trial conditions. Generalizing beyond them is an external-validity question the data cannot settle.
Etiology, Treatment & Trial Reading 🎯
Key Takeaways — Part 4
- Frameworks map to treatments. Behavioral → exposure, cognitive → restructuring, biological → drugs; biopsychosocial integrates.
- Exposure is extinction. Desensitization adds relaxation up a hierarchy; flooding starts at the top; response prevention blocks rituals.
- The drug-class map. SSRIs: depression, anxiety; benzodiazepines: short-term anxiety; lithium: bipolar; D2 blockers: psychosis.
- Criteria bookkeeping. 2 weeks MDD; 6 months GAD and schizophrenia; 1 month PTSD and panic's worry. Most wrong answers fail on duration.
Common traps
- Grading against baseline. Regression to the mean guarantees average improvement; compare arms, never baselines.
- Response proves cause. A treatment working, or failing, never proves a disorder's etiology, in either direction.
- p-value as importance. A significant difference can be tiny; check the effect size and functional outcomes.
- Pure samples generalize. Excluding comorbid patients helps internal validity but weakens external validity.